Diffusion Pharmaceuticals Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €46.29M +7,064.0% €1.02M -101.9% 2.2% +83 pp -€26.28M -49.7% -56.8% +80 pp
    (estimated) €646.16K +∞% -€53.48M +8.0% -8,277.3% -83 pp -€52.21M -9.6% -8,080.0% -81 pp
    (estimated) €0.00 -100.0% -€49.50M +28.3% N/A -€57.72M +3.6% N/A
    (estimated) €594.47K -87.4% -€38.59M +85.7% -6,491.3% -61 pp -€55.74M +150.8% -9,376.8% -89 pp
    (estimated) €4.72M -43.7% -€20.78M +48.1% -440.1% -2.7 pp -€22.23M +56.1% -470.8% -3.0 pp
    €8.39M +36.3% -€14.04M +650.0% -167.3% -1.4 pp -€14.24M +121.9% -169.8% -0.65 pp
    €6.16M +∞% -€1.87M -62.6% -30.4% -0.30 pp -€6.42M +189.6% -104.3% -1.0 pp
    €0.00 +NaN% -€5.00M -75.9% N/A -€2.22M -82.3% N/A
    €0.00 +NaN% -€20.76M +69.9% N/A -€12.49M +7.0% N/A
    €0.00 +NaN% -€12.22M +20.2% N/A -€11.68M +37.5% N/A
    €0.00 +NaN% -€10.17M -35.8% N/A -€8.49M -8.5% N/A
    €0.00 +NaN% -€15.83M +1,245.8% N/A -€9.28M -9.4% N/A
    €0.00 +NaN% -€1.18M -92.4% N/A -€10.24M +10.4% N/A
    €0.00 +NaN% -€15.54M +168.4% N/A -€9.28M +109.2% N/A
    €0.00 +NaN% -€5.79M -53.2% N/A -€4.43M -42.7% N/A
    €0.00 -100.0% -€12.37M +482.5% N/A -€7.74M +658.0% N/A
    €61.74K -80.9% -€2.12M -64.1% -3,438.1% -16 pp -€1.02M -72.5% -1,653.0% -5.0 pp
    €322.69K -34.3% -€5.92M -69.7% -1,834.0% +21 pp -€3.71M -63.8% -1,150.9% +9.4 pp
    €491.49K +1,319.5% -€19.50M +169.2% -3,967.9% +170 pp -€10.25M +504.8% -2,085.9% +28 pp
    €34.62K +∞% -€7.25M +147.3% -20,926.1% -210 pp -€1.70M +86.3% -4,895.6% -49 pp
    €0.00 -100.0% -€2.93M +62.5% N/A -€909.75K +108.7% N/A
    €34.62K -87.0% -€1.80M -21.5% -5,207.9% -43 pp -€435.90K -∞% -1,258.9% -13 pp
    €266.01K +∞% -€2.30M +5,443.1% -863.5% -8.6 pp €0.00 +NaN% 0.0% +0.0 pp
    €0.00 +NaN% -€41.44K -49.3% N/A €0.00 -100.0% N/A
    €0.00 -100.0% -€81.73K -98.8% N/A -€64.62K -99.0% N/A
    €23.21M -3.5% -€6.94M -4,130.0% -29.9% -0.31 pp -€6.40M +14.2% -27.6% -0.043 pp
    €24.05M €172.31K 0.7% -€5.60M -23.3%

    Notifications